The GARDP Foundation (known as GARDP) and the privately-owned, global biopharmaceutical company Debiopharm today announced that they have entered into a collaboration and license agreement to pursue ...

Real-world data show DoxyPEP implementation among PrEP users significantly reduces the incidence of chlamydia and syphilis.

Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. today appointed two obstetricians-gynecologists to the ...

The Coalition for Epidemic Preparedness Innovations (CEPI) announced earlier today that the University of Oxford has entered ...

The Pitt season 2 is already off to an intense start with numerous patients arriving at the Pittsburgh Trauma Medical ...

Edgewise Therapeutics, Inc., , a leading muscle disease biopharmaceutical company, today provided updates on the Company's clinical programs and highlighted major milestones for 2026. Edgewise Chief ...

A.M.’ is another excellent hour of television. During this second hour of this 4th of July shift, the big stories are ...

New options for testing and treating some of the most common sexually transmitted diseases are becoming available.

Evaxion adds autoimmune disease as a third disease area as it expands its therapeutic focusIn future, Evaxion's proprietary AI-Immunology platform will enable the discovery and development of drug can ...

Today, the world faces record levels of conflict and violence with a significant impact on people. In 2023 alone, over 170 armed conflicts were recorded. By the end of the year, nearly 120 million ...